ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · IEX Real-Time Price · USD
6.60
-0.14 (-2.08%)
Mar 28, 2024, 4:00 PM EDT - Market closed

ADMA Biologics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2011
Cash & Equivalents
51.3586.5251.0955.9226.7526.7548.619.9110.4717.23
Upgrade
Short-Term Investments
00000005.396.374.65
Upgrade
Cash & Cash Equivalents
51.3586.5251.0955.9226.7526.7548.6115.3116.8421.88
Upgrade
Cash Growth
-40.65%69.36%-8.64%109.03%-0.01%-44.96%217.59%-9.09%-23.05%-24.81%
Upgrade
Receivables
27.4215.5128.5813.243.471.393.881.020.920.38
Upgrade
Inventory
172.91163.28124.7281.5453.0618.6212.635.023.451.71
Upgrade
Other Current Assets
5.335.14.343.052.53-2.23-2.770.310.080.12
Upgrade
Total Current Assets
257.01270.4208.73153.7485.8244.5362.3421.6621.2924.09
Upgrade
Property, Plant & Equipment
63.4768.7558.245.8532.9930.1230.4722.432.84
Upgrade
Goodwill and Intangibles
4.034.545.265.976.697.538.38000
Upgrade
Other Long-Term Assets
4.674.774.072.111.66.76.830.03-0.010.09
Upgrade
Total Long-Term Assets
72.1778.0667.5253.9341.2744.3545.682.032.422.94
Upgrade
Total Assets
329.18348.46276.25207.67127.0988.88108.0223.6923.7127.02
Upgrade
Accounts Payable
15.6613.2312.4311.079.175.95.922.562.091.78
Upgrade
Deferred Revenue
1.871.982.122.262.42.552.692.842.981.58
Upgrade
Current Debt
1.050.910.590.370.230.0306.110.020.01
Upgrade
Other Current Liabilities
31.2323.1615.246.252.221.150.83-0.29-0.860.82
Upgrade
Total Current Liabilities
49.8139.2730.3819.9514.039.639.4411.224.224.2
Upgrade
Long-Term Debt
130.59142.8394.8792.9783.244.0842.9714.1115.6814.75
Upgrade
Other Long-Term Liabilities
13.5814.399.846.513.6715.4115.282.8132.06
Upgrade
Total Long-Term Liabilities
144.17157.22104.799.4886.8759.4858.2516.9218.6816.82
Upgrade
Total Liabilities
193.98196.49135.08119.42100.969.1167.6928.1422.8921.01
Upgrade
Total Debt
131.64143.7495.4693.3383.4344.142.9720.2215.6914.77
Upgrade
Debt Growth
-8.42%50.58%2.27%11.87%89.16%2.64%112.49%28.85%6.29%190.92%
Upgrade
Retained Earnings
-506.26-478.02-412.11-340.47-264.72-216.44-150.69-106.93-87.42-69.45
Upgrade
Shareholders' Equity
135.21151.97141.1788.2526.1919.7740.33-4.460.826.01
Upgrade
Net Cash / Debt
-80.29-57.22-44.37-37.41-56.68-17.355.64-4.921.147.11
Upgrade
Net Cash / Debt Growth
---------83.95%-70.39%
Upgrade
Net Cash Per Share
-0.36-0.29-0.32-0.43-1.04-0.380.25-0.400.110.77
Upgrade
Working Capital
207.21231.14178.35133.7971.7934.952.910.4317.0719.89
Upgrade
Book Value Per Share
0.600.771.011.020.480.441.76-0.370.080.65
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).